BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29196192)

  • 21. Lebein, a snake venom disintegrin, suppresses human colon cancer cells proliferation and tumor-induced angiogenesis through cell cycle arrest, apoptosis induction and inhibition of VEGF expression.
    Zakraoui O; Marcinkiewicz C; Aloui Z; Othman H; Grépin R; Haoues M; Essafi M; Srairi-Abid N; Gasmi A; Karoui H; Pagès G; Essafi-Benkhadir K
    Mol Carcinog; 2017 Jan; 56(1):18-35. PubMed ID: 26824338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemistry and pharmacology of proteins and peptides purified from the venoms of the snakes Macrovipera lebetina subspecies.
    Siigur J; Aaspõllu A; Siigur E
    Toxicon; 2019 Feb; 158():16-32. PubMed ID: 30472110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of salmosin, a Korean snake venom-derived disintegrin, on the integrin alphav-mediated proliferation of SK-Mel-2 human melanoma cells.
    Chung KH; Kim SH; Han KY; Sohn YD; Chang SI; Baek KH; Jang Y; Kim DS; Kang IC
    J Pharm Pharmacol; 2003 Nov; 55(11):1577-82. PubMed ID: 14713370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells.
    Zeng G; Liu J; Chen H; Liu B; Zhang Q; Li M; Zhu R
    Oncol Rep; 2014 Jun; 31(6):2713-9. PubMed ID: 24789439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lebestatin, a disintegrin from Macrovipera venom, inhibits integrin-mediated cell adhesion, migration and angiogenesis.
    Olfa KZ; José L; Salma D; Amine B; Najet SA; Nicolas A; Maxime L; Raoudha Z; Kamel M; Jacques M; Jean-Marc S; Mohamed el A; Naziha M
    Lab Invest; 2005 Dec; 85(12):1507-16. PubMed ID: 16200076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Venom Proteomics of Iranian,
    Ghezellou P; Dillenberger M; Kazemi SM; Jestrzemski D; Hellmann B; Spengler B
    Toxins (Basel); 2022 Oct; 14(10):. PubMed ID: 36287984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased cytotoxicity of cisplatin in SK-MEL 28 melanoma cells upon down-regulation of melanoma inhibitor of apoptosis protein.
    Mousavi-Shafaei P; Ziaee AA; Zangemeister-Wittke U
    Iran Biomed J; 2009 Jan; 13(1):27-34. PubMed ID: 19252675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Snake venom toxin inhibits cell growth through induction of apoptosis in neuroblastoma cells.
    Park MH; Son DJ; Kwak DH; Song HS; Oh KW; Yoo HS; Lee YM; Song MJ; Hong JT
    Arch Pharm Res; 2009 Nov; 32(11):1545-54. PubMed ID: 20091267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
    Dong YB; Yang HL; Elliott MJ; McMasters KM
    Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
    Bae SI; Cheriyath V; Jacobs BS; Reu FJ; Borden EC
    Oncogene; 2008 Jan; 27(4):490-8. PubMed ID: 17653094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taraxasterol attenuates melanoma progression via inactivation of reactive oxygen species-mediated PI3K/Akt signaling pathway.
    Liu W; Yu Q; Wang F; Li Y; Zhang G; Tao S
    Hum Exp Toxicol; 2022; 41():9603271211069034. PubMed ID: 35128947
    [No Abstract]   [Full Text] [Related]  

  • 33. Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17/EGFR/AKT/GSK3β axis.
    Huang L; Chen J; Quan J; Xiang D
    Bioengineered; 2021 Dec; 12(1):3065-3076. PubMed ID: 34224305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
    Li H; Niederkorn JY; Neelam S; Alizadeh H
    Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gambogic Acid Inhibits Melanoma through Regulation of miR-199a-3p/ZEB1 Signalling.
    Liang L; Zhang Z; Qin X; Gao Y; Zhao P; Liu J; Zeng W
    Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):692-703. PubMed ID: 29959879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Src homology 3 binding domain is required for lysophosphatidic acid 3 receptor-mediated cellular viability in melanoma cells.
    Jia W; Tran SK; Ruddick CA; Murph MM
    Cancer Lett; 2015 Jan; 356(2 Pt B):589-96. PubMed ID: 25304369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycyrrhizic acid inhibits DNA damage repair and enhances cisplatin-induced apoptosis of melanoma cells.
    Bian F; Niu FH; Qu PY; Gong F; Yan JZ
    Chem Biol Drug Des; 2024 May; 103(5):e14536. PubMed ID: 38725079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lebectin increases N-cadherin-mediated adhesion through PI3K/AKT pathway.
    Sarray S; Siret C; Lehmann M; Marrakchi N; Luis J; El Ayeb M; André F
    Cancer Lett; 2009 Nov; 285(2):174-81. PubMed ID: 19501458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.